Detalhe da pesquisa
1.
[What is recommended in the treatment of acute myeloid leukemia?] / Was ist gesichert in der Therapie der akuten myeloischen Leukämie?
Internist (Berl)
; 60(12): 1240-1250, 2019 Dec.
Artigo
Alemão
| MEDLINE | ID: mdl-31690995
2.
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO).
Ann Hematol
; 96(12): 1993-2003, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29090343
3.
Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia.
Klin Padiatr
; 227(3): 157-65, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25985449
4.
[Myelodysplastic syndromes]. / Myelodysplastische Syndrome.
Internist (Berl)
; 56(4): 364-73, 2015 Apr.
Artigo
Alemão
| MEDLINE | ID: mdl-25700647
5.
Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.
Ann Hematol
; 93(8): 1279-86, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24801015
6.
Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.
Sci Rep
; 13(1): 14809, 2023 09 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37684299
7.
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.
Leukemia
; 33(8): 1923-1933, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30728457
8.
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia.
Leukemia
; 32(1): 30-37, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28643785
9.
Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
Leukemia
; 31(6): 1286-1295, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27881874
10.
Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo.
Leukemia
; 31(10): 2020-2028, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28232670
11.
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure.
Leukemia
; 31(6): 1306-1313, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28138160
12.
Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate.
Leukemia
; 30(8): 1708-15, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27063596
13.
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.
Leukemia
; 30(11): 2160-2168, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27137476
14.
RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo.
Leukemia
; 32(1): 224-226, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28827563
15.
Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia.
Leukemia
; 26(2): 289-95, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21826063
16.
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group.
Leukemia
; 31(4): 1012-1015, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28090090
17.
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia.
Leukemia
; 31(5): 1217-1220, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28096533
18.
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups.
Leukemia
; 25(11): 1704-10, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21647152
19.
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.
Leukemia
; 30(11): 2282, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27804971
20.
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group.
Leukemia
; 30(11): 2248-2250, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27375010